Shorter telomeres in MSI+ cancers have previously been reported in tumors with TP53 wild-type status [13], but this was not confirmed in a corresponding subset analysis of our cohort (multivariate cRTL P=0.524, cRTL:nRTL ratio P=0.157). Here, TP53 is linked to cancer.